Heart Health Revolution: Unlocking Access to Advanced Cardiovascular Tests
In a significant development, Cardio Diagnostics Holdings, Inc. has announced a breakthrough in their mission to improve cardiovascular care. The Centers for Medicare and Medicaid Services (CMS) has finalized the payment rates for their innovative AI-driven tests, Epi+Gen CHD™ and PrecisionCHD™, at a higher rate of $854, compared to the preliminary rates of $350 and $684.76, respectively.
This news is a game-changer for heart health, especially for Medicare beneficiaries. With cardiovascular disease being the leading cause of death in the US, particularly among the elderly, these advanced tests offer a glimmer of hope.
But here's where it gets controversial...
AI-Powered Precision: A New Era in Cardiovascular Care
PrecisionCHD™ is a revolutionary test that utilizes artificial intelligence to analyze genetic and epigenetic markers, aiding in the diagnosis of coronary heart disease (CHD). Meanwhile, Epi+Gen CHD™ provides a three-year risk assessment for CHD events, such as heart attacks. Both tests are performed with a simple blood draw, offering a non-invasive and accessible approach to cardiovascular assessment.
And this is the part most people miss...
The Impact of CPT Codes and Accessibility
Both tests have been assigned dedicated CPT Proprietary Laboratory Analysis (PLA) codes by the American Medical Association: 0439U for Epi+Gen CHD and 0440U for PrecisionCHD. These codes, effective since April 1, 2024, are crucial for billing and reimbursement, ensuring that these advanced tests are accessible and affordable for patients.
Cardio Diagnostics' mission is to make cardiovascular disease prevention, detection, and management more personalized and precise. With their proprietary AI-driven technology, they aim to become a leading force in improving heart health outcomes.
A Step Towards a Healthier Future
The finalization of these payment rates is a significant step towards expanding access to advanced cardiovascular care. With over 700,000 Americans losing their lives to heart disease annually, this development couldn't have come at a better time.
What do you think about the potential of AI-driven precision medicine in transforming cardiovascular care? Share your thoughts and let's spark a conversation about the future of heart health!
